A serum metabolomic fingerprint of bevacizumab and temsirolimus combination as first-line treatment of metastatic renal cell carcinoma

por Jobard, Elodie, Blanc, Ellen, Négrier, Sylvie, Escudier, Bernard, Gravis, Gwenaelle, Chevreau, Christine, Elena-Herrmann, Bénédicte, Trédan, Olivier
Publicado 2015

Efficacy of high-intensity focused ultrasound-assisted hepatic resection (HIFU-AR) on blood loss reduction in patients with liver metastases requiring hepatectomy: study protocol f...

por Dupré, Aurélien, Pérol, David, Blanc, Ellen, Peyrat, Patrice, Basso, Valéria, Chen, Yao, Vincenot, Jérémy, Kocot, Anthony, Melodelima, David, Rivoire, Michel
Publicado 2017

Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors

por Négrier, Sylvie, Pérol, David, Bahleda, Rastislav, Hollebecque, Antoine, Chatelut, Etienne, Boyle, Helen, Cassier, Philippe, Metzger, Séverine, Blanc, Ellen, Soria, Jean-Charles, Escudier, Bernard
Publicado 2017

Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma

por de Vries-Brilland, Manon, Rioux-Leclercq, Nathalie, Meylan, Maxime, Dauvé, Jonathan, Passot, Christophe, Spirina-Menand, Elena, Flippot, Ronan, Fromont, Gaëlle, Gravis, Gwenaelle, Geoffrois, Lionnel, Chevreau, Christine, Rolland, Fréderic, Blanc, Ellen, Lefort, Félix, Ravaud, Alain, Gross-Goupil, Marine, Escudier, Bernard, Negrier, Sylvie, Albiges, Laurence
Publicado 2023

The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma

por Polena, Helena, Creuzet, Julie, Dufies, Maeva, Sidibé, Adama, Khalil-Mgharbel, Abir, Salomon, Aude, Deroux, Alban, Quesada, Jean-Louis, Roelants, Caroline, Filhol, Odile, Cochet, Claude, Blanc, Ellen, Ferlay-Segura, Céline, Borchiellini, Delphine, Ferrero, Jean-Marc, Escudier, Bernard, Négrier, Sylvie, Pages, Gilles, Vilgrain, Isabelle
Publicado 2018

A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3

por de la Fouchardière, Christelle, Gamradt, Pia, Chabaud, Sylvie, Raddaz, Maxime, Blanc, Ellen, Msika, Olivier, Treilleux, Isabelle, Bachy, Sophie, Cattey-Javouhey, Anne, Guibert, Pierre, Sarabi, Matthieu, Rochefort, Pauline, Funk-Debleds, Pamela, Coutzac, Clélia, Ray-Coquard, Isabelle, Peyrat, Patrice, Meeus, Pierre, Rivoire, Michel, Dupré, Aurélien, Hennino, Ana
Publicado 2022

Analysis of the StoRM cohort reveals physical activity to be associated with survival in metastatic breast cancer

por Delrieu, Lidia, Jacquet, Emmanuelle, Segura-Ferlay, Céline, Blanc, Ellen, Febvey-Combes, Olivia, Friedenreich, Christine, Romieu, Gilles, Jacot, William, Rios, Maria, Heudel, Pierre-Etienne, Roemer-Becuwe, Célia, Jouannaud, Christelle, Tredan, Olivier, Chaigneau, Loïc, Arnedos, Monica, Orfeuvre, Hubert, Quenel-Tueux, Nathalie, Jacquin, Jean-Philippe, Ferrero, Jean-Marc, Moullet, Isabelle, Abadie-Lacourtoisie, Sophie, Penault-Llorca, Frédérique, Cox, David, Bachelot, Thomas
Publicado 2020